Electron Jumping Compound / Molecular Battery Claim

The "electron jumping compound" (EJC) or "molecular battery" claim is the distinctive technical assertion of the source archive TSTO dossier: that tetrasilver tetroxide crystals release electrons through a reduction/oxidation (redox) process, and that this electron release "electrocutes pathogens." The claim is presented as the mechanism behind the material's asserted antimicrobial action.

The asserted mechanism

According to the page and the patent excerpts it quotes:

1. TSTO crystals act as individual "molecular devices" or "molecular batteries."
2. When activated by an oxidizing agent, each molecule releases two electrons.
3. The released electrons "electrocute pathogens."
4. The effect is claimed to be unique — "no other drug or anti-microbial functions with the unique method of action of TSTO — it is a new class of medicine."

The per-molecule calculation

The quoted patent text supplies a worked calculation:

• Each molecule releases two electrons.
• Each electron carries a charge of 4.8 × 10⁻¹⁰ e.s.u., equivalent to approximately 1.6 × 10⁻¹⁹ coulombs.
• The EMF for oxidation of Ag(I) to Ag(II) is given as 1.98 V (≈2.0 V), citing Antelman's Encyclopedia of Chemical Electrode Potentials (Plenum, 1982, p. 88).
• Using P = EI, per-electron power = 2.0 × 1.6 × 10⁻¹⁹ = 3.2 × 10⁻¹⁹ watts.
• Doubled for two electrons: 6.4 × 10⁻¹⁹ watts per molecule.

Unreconciled quantitative claims

The page header adds two figures that do not appear in the derivation:

• "releases ~10 kv of electrical energy through a reduction/oxidation process"
• "Power Flux = 4.0 volts EMF generated per molecule × Concentration (ppm) × 5"

Neither the "~10 kv" headline nor the "4.0 volts × ppm × 5" formula is derived, unit-consistent, or reconciled with the 6.4 × 10⁻¹⁹ watts/molecule figure. The source offers no measurement supporting any of them.

The activation caveat

The page states that the crystals "will not do so unless activated by an oxidizing agent such as Oxone or hydrogen peroxide." This is a significant qualification: the material is not self-activating, which complicates the "self-contained molecular battery" framing. The claim therefore describes a co-reactant-dependent redox process, not a spontaneous discharge.

Evidentiary status

The mechanism is asserted, not demonstrated. The source reports no experiment isolating the electron release, no measurement of pathogen electrocution, and no independent replication. The calculation is internally consistent as a per-molecule power estimate but does not establish that the described biological effect occurs. See Patent as Evidence and Tetrasilver Tetroxide: The Electron-Jumping Claim, the Patent Set and the Bounded Evidence.